BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14568630)

  • 1. Weighing gains and losses in criterion validity studies with test-based enrollment.
    Reichenheim ME
    J Clin Epidemiol; 2003 Oct; 56(10):983-8. PubMed ID: 14568630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient study designs to assess the accuracy of screening tests.
    Irwig L; Glasziou PP; Berry G; Chock C; Mock P; Simpson JM
    Am J Epidemiol; 1994 Oct; 140(8):759-69. PubMed ID: 7942777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure opportunity in epidemiologic studies.
    Schlesselman JJ; Stadel BV
    Am J Epidemiol; 1987 Feb; 125(2):174-8. PubMed ID: 3812426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal sampling strategies for two-stage studies.
    Reilly M
    Am J Epidemiol; 1996 Jan; 143(1):92-100. PubMed ID: 8533752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing cost-efficiency in mean exposure assessment--cost functions reconsidered.
    Mathiassen SE; Bolin K
    BMC Med Res Methodol; 2011 May; 11():76. PubMed ID: 21600023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.
    McNamee R
    Stat Med; 2002 Dec; 21(23):3609-25. PubMed ID: 12436459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical uncertainty due to misclassification: implications for validation substudies.
    Greenland S
    J Clin Epidemiol; 1988; 41(12):1167-74. PubMed ID: 3062138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new brief instrument for assessing decisional capacity for clinical research.
    Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC
    Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity: Part II.
    Davis DW
    Neonatal Netw; 2004; 23(3):74-6. PubMed ID: 15182122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficient designs for observational epidemiologic studies.
    Kalish LA; Begg CB
    Biometrics; 1987 Mar; 43(1):145-67. PubMed ID: 3567303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design effect and cluster samples: optimising tuberculosis prevalence surveys.
    Williams B; Gopi PG; Borgdorff MW; Yamada N; Dye C
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1110-5. PubMed ID: 18812038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-phase sampling for simultaneous prevalence estimation and case detection.
    McNamee R
    Biometrics; 2004 Sep; 60(3):783-92. PubMed ID: 15339302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Health Belief Model to test factors affecting patient retention in diabetes-related pharmaceutical care services.
    Pinto SL; Lively BT; Siganga W; Holiday-Goodman M; Kamm G
    Res Social Adm Pharm; 2006 Mar; 2(1):38-58. PubMed ID: 17138500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-efficient case-control cluster sampling designs for population-based epidemiological studies.
    Ly T; Cockburn M; Langholz B
    Spat Spatiotemporal Epidemiol; 2018 Aug; 26():95-105. PubMed ID: 30390934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design for exposure assessment in epidemiological studies.
    Armstrong B
    Sci Total Environ; 1995 Jun; 168(2):187-94. PubMed ID: 7481737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minmax designs for planning the second phase in a two-phase case-control study.
    Schill W; Wild P
    Stat Med; 2006 May; 25(10):1646-59. PubMed ID: 16158403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.
    Bouwmans C; Krol M; Severens H; Koopmanschap M; Brouwer W; Hakkaart-van Roijen L
    Value Health; 2015 Sep; 18(6):753-8. PubMed ID: 26409601
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.